Valuation Getinge AB Deutsche Boerse AG
Stocks
GTN
SE0000202624
Medical Equipment, Supplies & Distribution
|
Delayed
Deutsche Boerse AG
09:03:18 15/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 22.79 EUR | +0.62% |
|
+3.08% | +14.15% |
| 10-14 | Nordea sees risk of disappointment in Getinge ahead of report | FW |
| 10-13 | Espiria Sweden Small Cap fell 2.2 percent in September, Hansa Biopharma and Volvo Cars weighed | FW |
Company Valuation: Getinge AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 107,613 | 58,914 | 61,092 | 49,449 | 59,594 | 69,945 | - | - |
| Change | - | -45.25% | 3.7% | -19.06% | 20.52% | 17.37% | - | - |
| Enterprise Value (EV) 1 | 111,222 | 61,516 | 69,104 | 59,916 | 69,434 | 78,151 | 75,965 | 73,459 |
| Change | - | -44.69% | 12.34% | -13.3% | 15.89% | 12.55% | -2.8% | -3.3% |
| P/E | 36.2x | 23.6x | 25.3x | 30.2x | 26.4x | 22.1x | 19.6x | 17.3x |
| PBR | 4.27x | 1.93x | 2.01x | 1.49x | 2.02x | 2.18x | 2.04x | 1.89x |
| PEG | - | -1.5x | -7.98x | -0.9x | 0.7x | 0.5x | 1.5x | 1.3x |
| Capitalization / Revenue | 3.98x | 2.08x | 1.92x | 1.42x | 1.7x | 1.98x | 1.86x | 1.77x |
| EV / Revenue | 4.11x | 2.17x | 2.17x | 1.72x | 1.99x | 2.21x | 2.02x | 1.86x |
| EV / EBITDA | 16.5x | 10.4x | 12.4x | 9.02x | 10.6x | 10.9x | 9.77x | 8.71x |
| EV / EBIT | 22.5x | 15x | 18.9x | 13.2x | 15.5x | 15.4x | 13.6x | 11.9x |
| EV / FCF | 19.8x | 32.4x | 43.1x | 18.3x | 26.4x | 18.8x | 18.2x | 15.7x |
| FCF Yield | 5.06% | 3.08% | 2.32% | 5.45% | 3.79% | 5.32% | 5.5% | 6.37% |
| Dividend per Share 2 | 4 | 4.25 | 4.4 | 4.6 | 4.75 | 5.191 | 5.672 | 6.077 |
| Rate of return | 1.01% | 1.96% | 1.96% | 2.53% | 2.17% | 2.02% | 2.21% | 2.37% |
| EPS 2 | 10.9 | 9.15 | 8.86 | 6.01 | 8.29 | 11.62 | 13.12 | 14.83 |
| Distribution rate | 36.7% | 46.4% | 49.7% | 76.5% | 57.3% | 44.7% | 43.2% | 41% |
| Net sales 1 | 27,049 | 28,292 | 31,827 | 34,759 | 34,969 | 35,389 | 37,652 | 39,525 |
| EBITDA 1 | 6,754 | 5,891 | 5,574 | 6,646 | 6,581 | 7,192 | 7,777 | 8,432 |
| EBIT 1 | 4,939 | 4,096 | 3,653 | 4,549 | 4,494 | 5,059 | 5,598 | 6,151 |
| Net income 1 | 2,970 | 2,491 | 2,412 | 1,638 | 2,258 | 3,186 | 3,610 | 4,054 |
| Net Debt 1 | 3,609 | 2,602 | 8,012 | 10,467 | 9,840 | 8,206 | 6,021 | 3,515 |
| Reference price 2 | 395.10 | 216.30 | 224.30 | 181.55 | 218.80 | 256.80 | 256.80 | 256.80 |
| Nbr of stocks (in thousands) | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | 272,370 | - | - |
| Announcement Date | 1/28/22 A | 2/1/23 A | 2/1/24 A | 1/28/25 A | 1/27/26 A | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.38x | 4.03x | 15.56x | 2.5% | 178B | |
| 20.17x | 3.63x | 13.01x | 2.99% | 121B | |
| 21.93x | 4.3x | 15.02x | 1.28% | 108B | |
| 26.23x | 2.58x | 10.35x | 2.73% | 75.7B | |
| 18.44x | 0.21x | 13.38x | 0.71% | 64.15B | |
| 30.93x | 7.69x | 19.79x | 1.29% | 53.49B | |
| 36.4x | 3.49x | 11.96x | 2.08% | 51.45B | |
| 35.83x | 8.9x | 24.94x | -.--% | 41.68B | |
| 33.54x | 5.88x | 18.45x | -.--% | 31.5B | |
| Average | 28.20x | 4.52x | 15.83x | 1.51% | 80.52B | |
| Weighted average by Cap. | 26.85x | 4.11x | 15.04x | 1.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GETI B Stock
- GTN Stock
- Valuation Getinge AB
Select your edition
All financial news and data tailored to specific country editions
